< Back to latest news & events

Event

Funding for the Future

September 2020

Event date: 24th September 2020

As part of Leeds Digital Festival, Nexus is holding an event on Thursday 24th September 2020.

The main focus of this event is to deep dive into the investment landscape and COVID related impacts and opportunities for tech-led businesses.

Leaders and experts from private, not-for-profit and investment sectors will set the scene on the current state of play and share success stories from recent angel and venture capital deals, along with tips and IP essentials for dealmakers, investors and buyers.

HGF Partner Andy Camenisch will be hosting a breakout session 3 – IP essentials for entrepreneurs, dealmakers, investors, buyers.

Register now

Attendees

Andrew
Camenisch

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article
See all updates